We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Creo Medical Group Plc (CREO) Ord GBP0.001

Sell:30.50p Buy:31.00p 0 Change: 0.75p (2.38%)
Market closed Prices as at close on 26 February 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:30.50p
Buy:31.00p
Change: 0.75p (2.38%)
Market closed Prices as at close on 26 February 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:30.50p
Buy:31.00p
Change: 0.75p (2.38%)
Market closed Prices as at close on 26 February 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. It has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes by applying the benefits of advanced laparoscopic surgical technology to areas of therapy where there is significant unmet clinical need. CROMA delivers bipolar radiofrequency energy for precise localized cutting and focused high frequency microwave energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.

Contact details

Address:
Unit 2 Beaufort Park,, Beaufort Park Way
CHEPSTOW
NP16 5UH
United Kingdom
Telephone:
+44 (01291) 606005
Website:
https://creomedical.com/

Important dates

Future events
There are no future events available.
Past events
Trading Announcement 07 February 2024 07/02/24
Interim results 12 September 2023 12/09/23
Trading Announcement 03 August 2023 03/08/23
AGM 27 June 2023 27/06/23
Final results 26 May 2023 26/05/23
Annual report 26 May 2023 26/05/23

General stock information

EPIC:
CREO
ISIN:
GB00BZ1BLL44
Market cap:
£111.15 million
Shares in issue:
361.48 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Craig Gulliford
    Chief Executive Officer, Executive Director
  • Richard Rees
    Chief Financial Officer, Executive Director
  • Christopher Hancock
    Chief Technology Officer, Executive Director
  • David Woods
    Executive Director, Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.